Name /APrevent Medical Ltd.
Address /7F, No 520, Sec 5, Zhongshan N Rd, Shilin Dist, Taipei 11141, Taiwan
Name /Mark Chang
Title /COO & CTO
APrevent is a medical device company, founded in 2013 by a team of international clinically experienced physicians and engineers. APrevent's products improve voice and communication, focusing on the development of a long- term implant system and speech conversion platform for patients with glottic insufficiency and dysarthria.
The vocal implant system, VOIS, is a new solution for treating UVFP and medializes the vocal fold to the midline. This implant is made by silicone and titanium that have been used for medialization implants for decades. The implant is placed in the paraglottic space behind the patient’s thyroid cartilage to position a paralyzed vocal fold to a complete medialized position.
The VOIS has several state-of-the-art features, including: 1) intra- and postoperative adjustability to satisfy individual needs; 2) the concept and design of the implant mimics actual physiological mechanism (arytenoid rotation) to deliver better therapeutic result especially in the closure of the posterior glottis. 3) easy to perform, due to operative methods that are similar to current procedures; 4) time saving due to avoidance of multiple manipulation during surgery; 5) no revision surgeries needed for under- or overcorrection; 6) postoperative adjustability may also benefit less experienced surgeons; 7) benefits to those post medialization thyroplasty patients requiring intubation; 8) the procedure is easily and technically reversible. Based on these facts, VOIS is a novel thyroplasty implant with great competitive advantages.
Name /Arissa Mei